AUC | Group I | Group II | ||
---|---|---|---|---|
No. | % | No. | % | |
Detection of CAD, symptomatic with intermediate pretest probability, able to exercise. | 32 | 13.1 | 9 | 4.6 |
Detection of CAD, symptomatic with intermediate pretest probability, unable to exercise. | 9 | 3.7 | 3 | 1.5 |
Detection of CAD, symptomatic with high pretest probability. | 52 | 21.2 | 36 | 18.3 |
Risk assessment, post revascularization. | 19 | 7.8 | 67 | 34 |
Risk assessment, with known chronic stable angina and coronary stenosis. | 31 | 12.7 | 48 | 24.4 |
Detection of CAD, asymptomatic, high FRS | 8 | 3.3 | Â | Â |
Viability | 26 | 10.6 | 6 | 3 |
Evaluation of ventricular function, with use of cardiotoxic drugs | 2 | 0.8 | Â | Â |
Detection of CAD, symptomatic, with low or intermediate FRS. | 35 | 14.3 | 10 | 5.1 |
Known CAD, prior test result with normal coronary angiography | 2 | 0.8 | Â | Â |
Detection of CAD, symptomatic with low pretest probability. | Â | Â | 3 | 1.5 |
Post revascularization, asymptomatic. | 1 | 0.4 | Â | Â |
Risk assessment, known CAD. | 3 | 1.2 | 2 | 1 |
Risk assessment, post revascularization. | 25 | 10.2 | 9 | 4.6 |
Acute coronary syndrome, primary PCI, asymptomatic. | Â | Â | 4 | 2 |